MannKind Corp (MNKD) stock
MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30273% above fair value
$4.13−0.03 (-0.72%)
Close on Nov 13, 2026Market cap $1.33BP/E –Yield –
MannKind profit margin
Profit margin (net margin) is net income as a percentage of revenue.
MannKind's profit margin for the twelve months ending Sep 30, 2026 was -18.1%. For fiscal 2025 it was 1.7%, against 9.7% the year before. The highest annual figure on record is 71.9% in fiscal 2016.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.7% | −8.0 |
| FY2024 | Dec 31, 2024 | 9.7% | +15.7 |
| FY2023 | Dec 31, 2023 | -6.0% | +81.6 |
| FY2022 | Dec 31, 2022 | -87.6% | +19.7 |
| FY2021 | Dec 31, 2021 | -107.3% | −19.4 |
| FY2020 | Dec 31, 2020 | -87.9% | −5.5 |
| FY2019 | Dec 31, 2019 | -82.3% | +229.9 |
| FY2018 | Dec 31, 2018 | -312.2% | +686.8 |
| FY2017 | Dec 31, 2017 | -999.0% | −1070.9 |
| FY2016 | Dec 31, 2016 | 71.9% | +483974.8 |
| FY2012 | Dec 31, 2012 | -483902.9% | −162294.9 |
| FY2011 | Dec 31, 2011 | -321608.0% | −138210.2 |
| FY2010 | Dec 31, 2010 | -183397.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -22.8% | −32.5 |
| Q2 FY2026 | Jun 30, 2026 | -17.4% | −18.3 |
| Q1 FY2026 | Mar 31, 2026 | -18.4% | −35.2 |
| Q4 FY2025 | Dec 31, 2025 | -14.2% | −23.9 |
| Q3 FY2025 | Sep 30, 2025 | 9.7% | −6.8 |
| Q2 FY2025 | Jun 30, 2025 | 0.9% | +3.7 |
| Q1 FY2025 | Mar 31, 2025 | 16.8% | +0.8 |
| Q4 FY2024 | Dec 31, 2024 | 9.7% | +7.3 |
| Q3 FY2024 | Sep 30, 2024 | 16.5% | +13.1 |
| Q2 FY2024 | Jun 30, 2024 | -2.8% | +8.0 |
| Q1 FY2024 | Mar 31, 2024 | 16.0% | +40.2 |
| Q4 FY2023 | Dec 31, 2023 | 2.4% | +52.2 |
| Q3 FY2023 | Sep 30, 2023 | 3.4% | +47.3 |
| Q2 FY2023 | Jun 30, 2023 | -10.8% | +142.8 |
| Q1 FY2023 | Mar 31, 2023 | -24.1% | +192.7 |
| Q4 FY2022 | Dec 31, 2022 | -49.8% | +174.4 |
| Q3 FY2022 | Sep 30, 2022 | -44.0% | −24.0 |
| Q2 FY2022 | Jun 30, 2022 | -153.6% | −1.0 |
| Q1 FY2022 | Mar 31, 2022 | -216.8% | −142.7 |
| Q4 FY2021 | Dec 31, 2021 | -224.2% | −81.0 |
| Q3 FY2021 | Sep 30, 2021 | -19.9% | +53.4 |
| Q2 FY2021 | Jun 30, 2021 | -152.6% | −84.8 |
| Q1 FY2021 | Mar 31, 2021 | -74.1% | −16.7 |
| Q4 FY2020 | Dec 31, 2020 | -143.2% | −54.0 |
| Q3 FY2020 | Sep 30, 2020 | -73.3% | −2.3 |
| Q2 FY2020 | Jun 30, 2020 | -67.8% | +14.7 |
| Q1 FY2020 | Mar 31, 2020 | -57.4% | +27.9 |
| Q4 FY2019 | Dec 31, 2019 | -89.2% | −28.4 |
| Q3 FY2019 | Sep 30, 2019 | -71.1% | +469.7 |
| Q2 FY2019 | Jun 30, 2019 | -82.6% | +499.9 |
| Q1 FY2019 | Mar 31, 2019 | -85.3% | +791.6 |
| Q4 FY2018 | Dec 31, 2018 | -60.8% | +662.9 |
| Q3 FY2018 | Sep 30, 2018 | -540.8% | +1068.9 |
| Q2 FY2018 | Jun 30, 2018 | -582.5% | +1051.3 |
| Q1 FY2018 | Mar 31, 2018 | -876.9% | −334.4 |
| Q4 FY2017 | Dec 31, 2017 | -723.7% | −1158.9 |
| Q3 FY2017 | Sep 30, 2017 | -1609.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -1633.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -542.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 435.1% | – |
See a number that looks wrong?